EUVIMEDEUVIMED entdecken
Fallbericht

The u se of Vaccinia Immune Globulin in the Treatment of Severe Mpox. Virus Infection in Human Immunodeficiency Virus/AIDS

Andrea K Thet, Paul J Kelly, Sabirah N Kasule, Anish K Shah, Arpan Chawala, Amber Latif, Sridhar S Chilimuri, Cosmina B Zeana

Clinical Infectious Diseases · 03.05.2023 · 76 (9) · 1671-1673

DOI: 10.1093/cid/ciac971 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Infectious Diseases, online erschienen am 26.12.2022. Verfasst von Andrea K Thet und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, BronxCare Health System, Bronx, New York, USA. Hauptthemen laut MEDLINE: Vaccinia, Acquired Immunodeficiency Syndrome, Mpox, Monkeypox. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a case of progressive, severe mpox virus (MPXV) infection in a patient with AIDS despite a standard course of tecovirimat. He significantly improved after administration of vaccinia immune globulin intravenous (VIGIV) highlighting its use as an adjunct for severe disease in immunocompromised hosts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VacciniaAcquired Immunodeficiency SyndromeMpox, MonkeypoxMaleHumansHIVImmunoglobulinsImmunologic Factors

Stichwörter der Autor:innen

HIVimmune globulinmpoxtecovirimatvaccinia

Substanzen

ImmunoglobulinsImmunologic Factors

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Internal Medicine, BronxCare Health System, Bronx, New York, USA.
  • Internal Medicine Residency, Department of Internal Medicine, BronxCare Health System affiliated with Icahn School of Medicine at Mt Sinai, Bronx, New York, USA.
  • Department of Medicine, American University of the Caribbean School of Medicine, Cupecoy, St Marteen, USA.
  • Department of Internal Medicine, BronxCare Health System, Bronx, New York, USA.

Zitieren

APA

Thet, A. K., Kelly, P. J., Kasule, S. N., Shah, A. K., Chawala, A., Latif, A., Chilimuri, S. S., & Zeana, C. B. (2023). The u se of Vaccinia Immune Globulin in the Treatment of Severe Mpox. Virus Infection in Human Immunodeficiency Virus/AIDS. Clinical Infectious Diseases, 76(9), 1671-1673. https://doi.org/10.1093/cid/ciac971

Vancouver

Thet AK, Kelly PJ, Kasule SN, Shah AK, Chawala A, Latif A, et al. The u se of Vaccinia Immune Globulin in the Treatment of Severe Mpox. Virus Infection in Human Immunodeficiency Virus/AIDS. Clinical Infectious Diseases. 2023;76(9):1671-1673. doi:10.1093/cid/ciac971

BibTeX
@article{Thet2023,
  author = {Thet, Andrea K and Kelly, Paul J and Kasule, Sabirah N and Shah, Anish K and Chawala, Arpan and Latif, Amber and Chilimuri, Sridhar S and Zeana, Cosmina B},
  title = {The u se of Vaccinia Immune Globulin in the Treatment of Severe Mpox. Virus Infection in Human Immunodeficiency Virus/AIDS},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {9},
  pages = {1671--1673},
  doi = {10.1093/cid/ciac971}
}
Kostenlos starten →